Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.45185465 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.82379081 |
3 | negative regulation of cell killing (GO:0031342) | 5.82379081 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.29196072 |
5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.24013674 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.23322047 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.23322047 |
8 | modulation by symbiont of host immune response (GO:0052553) | 5.23322047 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.23322047 |
10 | modulation by symbiont of host defense response (GO:0052031) | 5.23322047 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.23322047 |
12 | neutrophil activation involved in immune response (GO:0002283) | 5.09653092 |
13 | cellular extravasation (GO:0045123) | 4.81850803 |
14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.74585314 |
15 | macrophage activation involved in immune response (GO:0002281) | 4.67745346 |
16 | response to peptidoglycan (GO:0032494) | 4.61303157 |
17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.61049737 |
18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.54100316 |
19 | detection of other organism (GO:0098543) | 4.40654496 |
20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.40414510 |
21 | negative regulation of interleukin-12 production (GO:0032695) | 4.39062119 |
22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.32487596 |
23 | detection of molecule of bacterial origin (GO:0032490) | 4.31921115 |
24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.10369148 |
25 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.05364814 |
26 | detection of bacterium (GO:0016045) | 4.04036883 |
27 | detection of external biotic stimulus (GO:0098581) | 4.01518591 |
28 | positive regulation of mast cell activation (GO:0033005) | 3.99656073 |
29 | microglial cell activation (GO:0001774) | 3.98850399 |
30 | negative thymic T cell selection (GO:0045060) | 3.97200846 |
31 | neutrophil activation (GO:0042119) | 3.94683988 |
32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.89800022 |
33 | negative T cell selection (GO:0043383) | 3.85913623 |
34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.81635731 |
35 | positive regulation of B cell differentiation (GO:0045579) | 3.79362387 |
36 | regulation of mast cell degranulation (GO:0043304) | 3.77655535 |
37 | B cell receptor signaling pathway (GO:0050853) | 3.75813421 |
38 | immunoglobulin mediated immune response (GO:0016064) | 3.75642037 |
39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.72431792 |
40 | granulocyte activation (GO:0036230) | 3.69580881 |
41 | myeloid cell activation involved in immune response (GO:0002275) | 3.66559080 |
42 | regulation of mast cell activation (GO:0033003) | 3.66070884 |
43 | leukocyte aggregation (GO:0070486) | 3.66018776 |
44 | respiratory burst (GO:0045730) | 3.65520110 |
45 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.62730339 |
46 | macrophage activation (GO:0042116) | 3.59916646 |
47 | regulation of B cell differentiation (GO:0045577) | 3.59473864 |
48 | neutrophil mediated immunity (GO:0002446) | 3.56189081 |
49 | positive regulation of mast cell degranulation (GO:0043306) | 3.54248055 |
50 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.54248055 |
51 | detection of biotic stimulus (GO:0009595) | 3.52428601 |
52 | response to host immune response (GO:0052572) | 3.51645250 |
53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.51645250 |
54 | positive thymic T cell selection (GO:0045059) | 3.46734988 |
55 | activated T cell proliferation (GO:0050798) | 3.45472016 |
56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.39181625 |
57 | response to muramyl dipeptide (GO:0032495) | 3.39178209 |
58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37209359 |
59 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.34829420 |
60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.31969697 |
61 | response to interleukin-15 (GO:0070672) | 3.28943472 |
62 | regulation of leukocyte degranulation (GO:0043300) | 3.25082317 |
63 | T cell selection (GO:0045058) | 3.23250580 |
64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.21319708 |
65 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.21299701 |
66 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.17010065 |
67 | response to host (GO:0075136) | 3.17010065 |
68 | response to host defenses (GO:0052200) | 3.17010065 |
69 | myeloid leukocyte mediated immunity (GO:0002444) | 3.12876976 |
70 | positive T cell selection (GO:0043368) | 3.11731402 |
71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07908129 |
72 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.07615474 |
73 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.07445009 |
74 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07012891 |
75 | regulation of T cell tolerance induction (GO:0002664) | 3.04446790 |
76 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02501492 |
77 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.02384284 |
78 | regulation of tolerance induction (GO:0002643) | 3.02206301 |
79 | interferon-gamma production (GO:0032609) | 3.01599928 |
80 | germinal center formation (GO:0002467) | 3.00288171 |
81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99423757 |
82 | defense response to protozoan (GO:0042832) | 2.98736239 |
83 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98601033 |
84 | T cell migration (GO:0072678) | 2.97319254 |
85 | leukocyte degranulation (GO:0043299) | 2.96621712 |
86 | dendritic cell migration (GO:0036336) | 2.95102293 |
87 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.93388283 |
88 | cellular response to interleukin-15 (GO:0071350) | 2.92152367 |
89 | B cell mediated immunity (GO:0019724) | 2.91737291 |
90 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88698628 |
91 | dendritic cell chemotaxis (GO:0002407) | 2.88051927 |
92 | myeloid leukocyte activation (GO:0002274) | 2.87615474 |
93 | regulation of antigen processing and presentation (GO:0002577) | 2.87433581 |
94 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86913234 |
95 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.85950106 |
96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.85950106 |
97 | positive regulation of antigen processing and presentation (GO:0002579) | 2.85250207 |
98 | thymic T cell selection (GO:0045061) | 2.84013275 |
99 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.81821881 |
100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81285207 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.74831717 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.66597438 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.58658585 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.13235622 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.03382352 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.75760938 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.69675187 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.52878298 |
9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.04903411 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.94707713 |
11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93719662 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82542137 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79082564 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.74452255 |
15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.64894445 |
16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.54790349 |
17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.54717481 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.51612789 |
19 | MYB_26560356_Chip-Seq_TH2_Human | 2.49088741 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45162290 |
21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.43149547 |
22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.39759752 |
23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.33698185 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28095825 |
25 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.25954117 |
26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17301733 |
27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12601373 |
28 | MAF_26560356_Chip-Seq_TH1_Human | 2.08358365 |
29 | MYB_26560356_Chip-Seq_TH1_Human | 2.03423443 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02487078 |
31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01564421 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96549076 |
33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95370635 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93597616 |
35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.89548354 |
36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78764267 |
37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76066257 |
38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74910301 |
39 | MYC_22102868_ChIP-Seq_BL_Human | 1.72333805 |
40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59228157 |
41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56952417 |
42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54888617 |
43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52713096 |
44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52490178 |
45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52303307 |
46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50879565 |
47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50283360 |
48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50253560 |
49 | MAF_26560356_Chip-Seq_TH2_Human | 1.49985876 |
50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48533847 |
51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45060648 |
52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.41332863 |
53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40487859 |
54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36083561 |
55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29837640 |
56 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28764932 |
57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27192552 |
58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26866729 |
59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24989160 |
60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21633660 |
61 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21298382 |
62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20785402 |
63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20227512 |
64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20065436 |
65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19926659 |
66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19154465 |
67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17905074 |
68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17263841 |
69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16900735 |
70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15139406 |
71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14591640 |
72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13711193 |
73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13709332 |
74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09709941 |
75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09427590 |
76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05177708 |
77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04946489 |
78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02929036 |
79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00263726 |
80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99091306 |
81 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96103263 |
82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94678887 |
83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94192599 |
84 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93405119 |
85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93042664 |
86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87046583 |
87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85453112 |
88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82274019 |
89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81722630 |
90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80256406 |
91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77020101 |
92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75777134 |
93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73883613 |
94 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72508768 |
95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.70874203 |
96 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.70330342 |
97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70281539 |
98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.68663257 |
99 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67400203 |
100 | GATA3_26560356_Chip-Seq_TH1_Human | 0.66919125 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.26695722 |
2 | MP0001835_abnormal_antigen_presentation | 3.83658148 |
3 | MP0003436_decreased_susceptibility_to | 3.77019805 |
4 | MP0003303_peritoneal_inflammation | 3.45167509 |
5 | MP0005671_abnormal_response_to | 3.41355234 |
6 | MP0002419_abnormal_innate_immunity | 3.09001537 |
7 | MP0001800_abnormal_humoral_immune | 2.95935531 |
8 | MP0000685_abnormal_immune_system | 2.79656896 |
9 | MP0005000_abnormal_immune_tolerance | 2.78084534 |
10 | MP0006082_CNS_inflammation | 2.77807878 |
11 | MP0001790_abnormal_immune_system | 2.76334087 |
12 | MP0005387_immune_system_phenotype | 2.76334087 |
13 | MP0005025_abnormal_response_to | 2.69917123 |
14 | MP0003172_abnormal_lysosome_physiology | 2.65442276 |
15 | MP0002452_abnormal_antigen_presenting | 2.62676567 |
16 | MP0002723_abnormal_immune_serum | 2.59133639 |
17 | MP0009785_altered_susceptibility_to | 2.56993067 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.52257828 |
19 | MP0002420_abnormal_adaptive_immunity | 2.48702814 |
20 | MP0001819_abnormal_immune_cell | 2.46360182 |
21 | MP0005464_abnormal_platelet_physiology | 2.31796177 |
22 | MP0003300_gastrointestinal_ulcer | 2.23409252 |
23 | MP0003763_abnormal_thymus_physiology | 2.15460388 |
24 | MP0001533_abnormal_skeleton_physiology | 2.01940489 |
25 | MP0002405_respiratory_system_inflammati | 1.99047146 |
26 | MP0009278_abnormal_bone_marrow | 1.92962801 |
27 | MP0003191_abnormal_cellular_cholesterol | 1.90268742 |
28 | MP0000716_abnormal_immune_system | 1.88236436 |
29 | MP0002398_abnormal_bone_marrow | 1.87999012 |
30 | MP0005058_abnormal_lysosome_morphology | 1.81087255 |
31 | MP0000569_abnormal_digit_pigmentation | 1.78371860 |
32 | MP0005310_abnormal_salivary_gland | 1.75226424 |
33 | MP0001845_abnormal_inflammatory_respons | 1.73177820 |
34 | MP0003828_pulmonary_edema | 1.72554449 |
35 | MP0010155_abnormal_intestine_physiology | 1.72503046 |
36 | MP0005451_abnormal_body_composition | 1.68469533 |
37 | MP0004947_skin_inflammation | 1.66361393 |
38 | MP0009764_decreased_sensitivity_to | 1.66039142 |
39 | MP0000689_abnormal_spleen_morphology | 1.64750757 |
40 | MP0008260_abnormal_autophagy | 1.63912326 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.59542597 |
42 | MP0001545_abnormal_hematopoietic_system | 1.59542597 |
43 | MP0002722_abnormal_immune_system | 1.52963170 |
44 | MP0004381_abnormal_hair_follicle | 1.49936676 |
45 | MP0009333_abnormal_splenocyte_physiolog | 1.49285755 |
46 | MP0002132_abnormal_respiratory_system | 1.48517133 |
47 | MP0002429_abnormal_blood_cell | 1.46081788 |
48 | MP0002998_abnormal_bone_remodeling | 1.45138631 |
49 | MP0004883_abnormal_blood_vessel | 1.44933109 |
50 | MP0003183_abnormal_peptide_metabolism | 1.43224285 |
51 | MP0008469_abnormal_protein_level | 1.39268025 |
52 | MP0000465_gastrointestinal_hemorrhage | 1.37151114 |
53 | MP0000703_abnormal_thymus_morphology | 1.33872396 |
54 | MP0000604_amyloidosis | 1.30720701 |
55 | MP0000015_abnormal_ear_pigmentation | 1.29464964 |
56 | MP0003690_abnormal_glial_cell | 1.28737888 |
57 | MP0003866_abnormal_defecation | 1.26975967 |
58 | MP0002396_abnormal_hematopoietic_system | 1.26114478 |
59 | MP0002166_altered_tumor_susceptibility | 1.22608674 |
60 | MP0001851_eye_inflammation | 1.20334869 |
61 | MP0001853_heart_inflammation | 1.16648384 |
62 | MP0000858_altered_metastatic_potential | 1.16405810 |
63 | MP0003075_altered_response_to | 1.12625016 |
64 | MP0002138_abnormal_hepatobiliary_system | 1.11292457 |
65 | MP0005174_abnormal_tail_pigmentation | 1.06358106 |
66 | MP0001986_abnormal_taste_sensitivity | 1.06266833 |
67 | MP0003656_abnormal_erythrocyte_physiolo | 1.05323019 |
68 | MP0000343_altered_response_to | 1.04857823 |
69 | MP0005164_abnormal_response_to | 1.04402791 |
70 | MP0002009_preneoplasia | 1.04189881 |
71 | MP0005075_abnormal_melanosome_morpholog | 1.01613928 |
72 | MP0002277_abnormal_respiratory_mucosa | 0.99760706 |
73 | MP0008004_abnormal_stomach_pH | 0.99487367 |
74 | MP0003448_altered_tumor_morphology | 0.97849066 |
75 | MP0005167_abnormal_blood-brain_barrier | 0.97113286 |
76 | MP0005166_decreased_susceptibility_to | 0.85677127 |
77 | MP0004130_abnormal_muscle_cell | 0.83291964 |
78 | MP0002006_tumorigenesis | 0.82260304 |
79 | MP0009840_abnormal_foam_cell | 0.80295271 |
80 | MP0000249_abnormal_blood_vessel | 0.79616918 |
81 | MP0001663_abnormal_digestive_system | 0.78816933 |
82 | MP0000371_diluted_coat_color | 0.77835525 |
83 | MP0009763_increased_sensitivity_to | 0.76167985 |
84 | MP0004510_myositis | 0.75284747 |
85 | MP0004808_abnormal_hematopoietic_stem | 0.74471679 |
86 | MP0002933_joint_inflammation | 0.72538565 |
87 | MP0005390_skeleton_phenotype | 0.70940748 |
88 | MP0009765_abnormal_xenobiotic_induced | 0.69085695 |
89 | MP0001873_stomach_inflammation | 0.68633506 |
90 | MP0000920_abnormal_myelination | 0.68457254 |
91 | MP0008874_decreased_physiological_sensi | 0.66149591 |
92 | MP0003045_fibrosis | 0.65799987 |
93 | MP0003795_abnormal_bone_structure | 0.62840837 |
94 | MP0009115_abnormal_fat_cell | 0.54543355 |
95 | MP0000490_abnormal_crypts_of | 0.53931792 |
96 | MP0003329_amyloid_beta_deposits | 0.53707234 |
97 | MP0003091_abnormal_cell_migration | 0.53080631 |
98 | MP0002133_abnormal_respiratory_system | 0.51832186 |
99 | MP0005388_respiratory_system_phenotype | 0.51832186 |
100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49328601 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 6.10711006 |
2 | Recurrent abscess formation (HP:0002722) | 6.04867129 |
3 | Eczematoid dermatitis (HP:0000976) | 5.98125842 |
4 | Abnormality of macrophages (HP:0004311) | 5.06886058 |
5 | Myositis (HP:0100614) | 5.00492019 |
6 | Orchitis (HP:0100796) | 4.68164013 |
7 | Optic neuritis (HP:0100653) | 4.62428620 |
8 | Retrobulbar optic neuritis (HP:0100654) | 4.62428620 |
9 | Stomatitis (HP:0010280) | 4.59575316 |
10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.56414175 |
11 | Recurrent fungal infections (HP:0002841) | 4.47020367 |
12 | Recurrent skin infections (HP:0001581) | 4.11434579 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 4.04319108 |
14 | T lymphocytopenia (HP:0005403) | 3.99984304 |
15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.99449002 |
16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.99449002 |
17 | Spontaneous hematomas (HP:0007420) | 3.98648832 |
18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93431008 |
19 | Meningitis (HP:0001287) | 3.76645776 |
20 | Abnormality of T cell number (HP:0011839) | 3.72068768 |
21 | Obstructive lung disease (HP:0006536) | 3.59105428 |
22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.59105428 |
23 | Gastrointestinal infarctions (HP:0005244) | 3.58838503 |
24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.53965667 |
25 | Increased cerebral lipofuscin (HP:0011813) | 3.49593952 |
26 | Encephalitis (HP:0002383) | 3.46798384 |
27 | Keratoconjunctivitis sicca (HP:0001097) | 3.46738953 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.41778969 |
29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.41778969 |
30 | Abnormality of glycolipid metabolism (HP:0010969) | 3.41778969 |
31 | Panhypogammaglobulinemia (HP:0003139) | 3.36230984 |
32 | Keratoconjunctivitis (HP:0001096) | 3.34953930 |
33 | Vasculitis (HP:0002633) | 3.27522004 |
34 | Gingivitis (HP:0000230) | 3.24858565 |
35 | Recurrent viral infections (HP:0004429) | 3.24222151 |
36 | Vacuolated lymphocytes (HP:0001922) | 3.19246116 |
37 | Prolonged bleeding time (HP:0003010) | 3.10886677 |
38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.06549580 |
39 | Leukocytosis (HP:0001974) | 3.05320019 |
40 | Hemoptysis (HP:0002105) | 3.05105787 |
41 | Pustule (HP:0200039) | 3.00846086 |
42 | Gingival bleeding (HP:0000225) | 2.94981093 |
43 | Pulmonary infiltrates (HP:0002113) | 2.94509505 |
44 | Abnormality of T cells (HP:0002843) | 2.92116108 |
45 | Urticaria (HP:0001025) | 2.89503368 |
46 | Chest pain (HP:0100749) | 2.86906953 |
47 | Epistaxis (HP:0000421) | 2.86368783 |
48 | Inflammation of the large intestine (HP:0002037) | 2.82473002 |
49 | Hematochezia (HP:0002573) | 2.68716472 |
50 | Arterial thrombosis (HP:0004420) | 2.67798792 |
51 | Gastrointestinal inflammation (HP:0004386) | 2.64106535 |
52 | Granulocytopenia (HP:0001913) | 2.60047534 |
53 | Cellulitis (HP:0100658) | 2.59078456 |
54 | Increased IgE level (HP:0003212) | 2.53329637 |
55 | Pulmonary embolism (HP:0002204) | 2.50659150 |
56 | Dysostosis multiplex (HP:0000943) | 2.48983308 |
57 | Disinhibition (HP:0000734) | 2.48448877 |
58 | Eosinophilia (HP:0001880) | 2.46141082 |
59 | Loss of speech (HP:0002371) | 2.42391109 |
60 | Petechiae (HP:0000967) | 2.42388469 |
61 | Colitis (HP:0002583) | 2.42020314 |
62 | Autoimmune thrombocytopenia (HP:0001973) | 2.39671781 |
63 | Amyloidosis (HP:0011034) | 2.34188371 |
64 | Increased IgM level (HP:0003496) | 2.29431862 |
65 | Episodic fever (HP:0001954) | 2.28001877 |
66 | Anorexia (HP:0002039) | 2.27940858 |
67 | Osteomyelitis (HP:0002754) | 2.25198955 |
68 | Abnormality of eosinophils (HP:0001879) | 2.19409346 |
69 | Lymphopenia (HP:0001888) | 2.19087458 |
70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16826838 |
71 | Purpura (HP:0000979) | 2.15886238 |
72 | Abnormality of T cell physiology (HP:0011840) | 2.15571260 |
73 | Gangrene (HP:0100758) | 2.11543405 |
74 | Agammaglobulinemia (HP:0004432) | 2.09575081 |
75 | Systemic lupus erythematosus (HP:0002725) | 2.09364895 |
76 | Abnormality of the pleura (HP:0002103) | 2.08822517 |
77 | Hypochromic anemia (HP:0001931) | 2.07300992 |
78 | Sepsis (HP:0100806) | 2.06861430 |
79 | Severe combined immunodeficiency (HP:0004430) | 2.04221970 |
80 | Viral hepatitis (HP:0006562) | 2.00977426 |
81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99485451 |
82 | Vertigo (HP:0002321) | 1.96719901 |
83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94874506 |
84 | Peritonitis (HP:0002586) | 1.94831127 |
85 | Combined immunodeficiency (HP:0005387) | 1.94777023 |
86 | Polyneuropathy (HP:0001271) | 1.94511454 |
87 | Hypochromic microcytic anemia (HP:0004840) | 1.94234363 |
88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93649534 |
89 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93649534 |
90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93649534 |
91 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.91993111 |
92 | Keratitis (HP:0000491) | 1.91910663 |
93 | Hepatosplenomegaly (HP:0001433) | 1.90559849 |
94 | Restrictive lung disease (HP:0002091) | 1.89891377 |
95 | Abnormality of the endocardium (HP:0004306) | 1.88185681 |
96 | Recurrent pneumonia (HP:0006532) | 1.88125352 |
97 | Glomerulopathy (HP:0100820) | 1.87122728 |
98 | Slow saccadic eye movements (HP:0000514) | 1.86033457 |
99 | Papilloma (HP:0012740) | 1.83407938 |
100 | Verrucae (HP:0200043) | 1.83407938 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.49932937 |
2 | BLK | 4.09011445 |
3 | MAP4K1 | 3.43203035 |
4 | TYK2 | 2.83907994 |
5 | TXK | 2.68901802 |
6 | IRAK4 | 2.63772179 |
7 | CSK | 2.57554214 |
8 | FES | 2.55050180 |
9 | MAP3K14 | 2.14926831 |
10 | MAP2K3 | 2.11983893 |
11 | ZAP70 | 2.01206932 |
12 | SYK | 1.94050407 |
13 | PRPF4B | 1.93533439 |
14 | BTK | 1.90419939 |
15 | JAK3 | 1.86546299 |
16 | GRK6 | 1.84133380 |
17 | FGR | 1.84127534 |
18 | TAOK3 | 1.82467753 |
19 | HCK | 1.75389353 |
20 | CSF1R | 1.74306613 |
21 | TNK2 | 1.70063224 |
22 | MAP3K13 | 1.68170440 |
23 | ERN1 | 1.62418479 |
24 | IKBKE | 1.59942887 |
25 | LYN | 1.50502397 |
26 | JAK1 | 1.49903293 |
27 | ITK | 1.49110838 |
28 | TGFBR2 | 1.48781458 |
29 | TEC | 1.43373414 |
30 | JAK2 | 1.40396055 |
31 | CAMKK2 | 1.35802702 |
32 | YES1 | 1.34519126 |
33 | MARK3 | 1.28707179 |
34 | IRAK1 | 1.25590102 |
35 | LCK | 1.22601528 |
36 | MAP3K3 | 1.19378698 |
37 | SIK3 | 1.18374646 |
38 | IKBKB | 1.15084079 |
39 | TBK1 | 1.14062573 |
40 | KIT | 1.07875922 |
41 | ACVR1B | 1.07505873 |
42 | IRAK2 | 1.04190365 |
43 | EPHB1 | 1.03660667 |
44 | TAOK1 | 1.03467824 |
45 | BMPR2 | 0.99676821 |
46 | MAP3K11 | 0.97495375 |
47 | CAMKK1 | 0.97420109 |
48 | STK10 | 0.95606740 |
49 | MATK | 0.95324305 |
50 | MAP3K1 | 0.95171425 |
51 | GRK7 | 0.94156823 |
52 | FRK | 0.93673849 |
53 | PDK1 | 0.93200093 |
54 | SIK2 | 0.88753432 |
55 | PIK3CG | 0.85568856 |
56 | CDK19 | 0.84217261 |
57 | MARK2 | 0.82407087 |
58 | PRKD2 | 0.75685032 |
59 | KSR2 | 0.73372308 |
60 | CDC42BPA | 0.73012595 |
61 | PDPK1 | 0.71677071 |
62 | PRKCQ | 0.70224076 |
63 | MAPK7 | 0.68698066 |
64 | CAMK1D | 0.68281865 |
65 | MAPK12 | 0.65833752 |
66 | FGFR3 | 0.64827798 |
67 | PTK2B | 0.63726735 |
68 | NLK | 0.62686052 |
69 | PIM1 | 0.61687940 |
70 | MAP3K2 | 0.60146301 |
71 | MAP3K7 | 0.57590555 |
72 | SGK3 | 0.56656541 |
73 | FYN | 0.56352602 |
74 | SGK2 | 0.55227024 |
75 | RPS6KL1 | 0.53028133 |
76 | RPS6KC1 | 0.53028133 |
77 | CDK6 | 0.52937673 |
78 | RPS6KA6 | 0.52625940 |
79 | DYRK1B | 0.52599320 |
80 | CAMK4 | 0.50906700 |
81 | MAP3K10 | 0.50237768 |
82 | PTK6 | 0.49031151 |
83 | HIPK2 | 0.48789308 |
84 | ADRBK2 | 0.47566742 |
85 | STK11 | 0.46668307 |
86 | EPHA3 | 0.44380236 |
87 | MAP3K5 | 0.44005372 |
88 | TAOK2 | 0.43055413 |
89 | WNK1 | 0.42737032 |
90 | DAPK2 | 0.42663492 |
91 | LRRK2 | 0.41358232 |
92 | NEK9 | 0.40199184 |
93 | CDK12 | 0.39021673 |
94 | IRAK3 | 0.38633670 |
95 | MAP3K6 | 0.33458165 |
96 | ABL1 | 0.33096982 |
97 | CHUK | 0.32837991 |
98 | KSR1 | 0.32592997 |
99 | PRKCH | 0.31521878 |
100 | RAF1 | 0.30993472 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.04096546 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.98680076 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.87641175 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.55796738 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.53884097 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.37600094 |
7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30424307 |
8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.27276842 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.24029696 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05921014 |
11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.99945335 |
12 | Asthma_Homo sapiens_hsa05310 | 1.97725371 |
13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.97575888 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93160406 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91547230 |
16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.87872845 |
17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86818557 |
18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.85194417 |
19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82210564 |
20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74781017 |
21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73863747 |
22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.65041583 |
23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64048654 |
24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.59846697 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56360160 |
26 | Malaria_Homo sapiens_hsa05144 | 1.55561226 |
27 | Lysosome_Homo sapiens_hsa04142 | 1.49748820 |
28 | Measles_Homo sapiens_hsa05162 | 1.49136139 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.48895930 |
30 | Phagosome_Homo sapiens_hsa04145 | 1.47156762 |
31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44388667 |
32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44027957 |
33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39537417 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.35333482 |
35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31128315 |
36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29960694 |
37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29643110 |
38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23255200 |
39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21185309 |
40 | Platelet activation_Homo sapiens_hsa04611 | 1.20882830 |
41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20623241 |
42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14987733 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.08727599 |
44 | Pertussis_Homo sapiens_hsa05133 | 1.07070905 |
45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03306362 |
46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03248907 |
47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96189669 |
48 | Apoptosis_Homo sapiens_hsa04210 | 0.88012153 |
49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86768292 |
50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85656771 |
51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85116523 |
52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84121114 |
53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82707639 |
54 | Hepatitis C_Homo sapiens_hsa05160 | 0.80647486 |
55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80365144 |
56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79842589 |
57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78072725 |
58 | Salmonella infection_Homo sapiens_hsa05132 | 0.75815397 |
59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73557323 |
60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73463562 |
61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72839282 |
62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72204268 |
63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71820535 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70702880 |
65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69364155 |
66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66745802 |
67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66300109 |
68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65891759 |
69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65452780 |
70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64569417 |
71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64208679 |
72 | Shigellosis_Homo sapiens_hsa05131 | 0.61522519 |
73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59947299 |
74 | Endocytosis_Homo sapiens_hsa04144 | 0.58038769 |
75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55709897 |
76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52619062 |
77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51031872 |
78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50686805 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48374515 |
80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46793683 |
81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46277911 |
82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46183213 |
83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45898607 |
84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45276034 |
85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43990346 |
86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43898507 |
87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43889017 |
88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43287336 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.41937442 |
90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40665089 |
91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39865794 |
92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39486979 |
93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38647237 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.35709045 |
95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35121435 |
96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31623911 |
97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29648476 |
98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29497588 |
99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29146993 |
100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28671500 |